English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/212653
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Neurokinin-1 receptor antagonists against hepatoblastoma

AuthorsMuñoz Sáez, Miguel; Rosso González, M.; Coveñas, Rafael
KeywordsNK-1 receptor
Substance P
Hepatoblastoma
Aprepitant
Antitumor
Apoptosis
Angiogenesis
Issue Date2019
PublisherMultidisciplinary Digital Publishing Institute
CitationCancers 11(9): 1258 (2019)
AbstractHepatoblastoma (HB) is the most common malignant liver tumor that occurs during childhood. The prognosis of children with HB is favorable when a complete surgical resection of the tumor is possible, but for high-risk patients, the prognosis is much worse. New anti-HB strategies must be urgently developed. The undecapeptide substance P (SP) after binding to the neurokinin-1 receptor (NK-1R), regulates cancer cell proliferation, exerts an antiapoptotic effect, induces cell migration for invasion/metastasis, and triggers endothelial cell proliferation for neoangiogenesis. HB samples and cell lines overexpress NK-1R (the truncated form) and SP elicits HB cell proliferation. One of these strategies could be the use of non-peptide NK-1R antagonists. These antagonists exert, in a concentration-dependent manner, an antiproliferative action against HB cells (inhibit cell proliferation and induce the death of HB cells by apoptosis). NK-1R antagonists exerted a dual effect in HB: Decreased both tumor volume and angiogenic activity. Thus, the SP/NK-1R system is an important target in the HB treatment and NK-1R antagonists could act as specific drugs against HB cells. In this review, we update and discuss the use of NK-1R antagonists in the treatment of HB.
DescriptionThis article belongs to the Special Issue Hepatoblastoma and Pediatric Liver Tumors.
Publisher version (URL)https://doi.org/10.3390/cancers11091258
URIhttp://hdl.handle.net/10261/212653
Identifiersdoi: 10.3390/cancers11091258
e-issn: 2072-6694
Appears in Collections:(IBIS) Artículos
Files in This Item:
File Description SizeFormat 
neurokin.pdf931,02 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.